Illinois House Bill 4888 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 21-1)
Status: Introduced on February 13 2020 - 25% progression, died in committee
Action: 2020-06-23 - Rule 19(b) / Re-referred to Rules Committee
Pending: House Rules Committee
Text: Latest bill text (Introduced) [HTML]

Creates the Pharmaceutical Recovery Act. Requires covered manufacturers to, no later than July 1, 2021 or 6 months after becoming a covered manufacturer, whichever is later, participate in an approved drug take-back program or have established and implemented a drug take-back program independently or as part of a group of covered manufacturers. Provides requirements for the drug take-back program and for manufacturer program operators. Requires each manufacturer program operator to submit a proposal for the establishment and implementation of a drug take-back program to the Environmental Protection Agency for review and approval. Contains provisions regarding changes or modifications to drug take-back programs, promotion of drug take-back programs, annual reports, funding, and reimbursement. Requires covered manufacturers and manufacturer program operators to submit an annual $5,000 registration fee. Provides civil penalties. Creates the Pharmaceutical Take-Back Reimbursement Program Fund and makes a conforming change in the State Finance Act. Contains other provisions. Amends the Freedom of Information Act. Provides that proprietary information submitted to the Environmental Protection Agency under the Pharmaceutical Recovery Act is exempt from inspection and copying under the Act. Effective immediately.

PHARMACEUTICAL TAKE-BACK

Rep. Jennifer Gong-Gershowitz [D]	Rep. Fred Crespo [D]	Rep. Marcus Evans [D]	Rep. Grant Wehrli [R]
Rep. Terra Costa Howard [D]	Rep. Daniel Didech [D]	Sen. Mary Edly-Allen [D]	Rep. Bob Morgan [D]
Rep. LaShawn Ford [D]	Rep. Robyn Gabel [D]	Rep. Jonathan Pizer [D]	Rep. Katie Stuart [D]
Rep. Kelly Cassidy [D]	Sen. John Connor [D]	Rep. Will Guzzardi [D]	Rep. Ann Williams [D]
Rep. Deborah Conroy [D]	Rep. Anne Stava-Murray [D]	Rep. Barbara Hernandez [D]	Rep. Michelle Mussman [D]
Rep. Theresa Mah [D]	Rep. Rita Mayfield [D]

Date	Chamber	Action
2020-06-23	House	Rule 19(b) / Re-referred to Rules Committee
2020-03-10	House	Added Co-Sponsor Rep. Rita Mayfield
2020-02-27	House	Added Co-Sponsor Rep. Theresa Mah
2020-02-27	House	Added Co-Sponsor Rep. Michelle Mussman
2020-02-25	House	Added Co-Sponsor Rep. Barbara Hernandez
2020-02-25	House	Assigned to Prescription Drug Affordability & Accessibility Committee
2020-02-24	House	Added Co-Sponsor Rep. Anne Stava-Murray
2020-02-20	House	Added Co-Sponsor Rep. Deb Conroy
2020-02-20	House	Added Co-Sponsor Rep. Ann M. Williams
2020-02-20	House	Added Co-Sponsor Rep. Will Guzzardi
2020-02-20	House	Added Co-Sponsor Rep. John Connor
2020-02-20	House	Added Co-Sponsor Rep. Kelly M. Cassidy
2020-02-18	House	Added Co-Sponsor Rep. Katie Stuart
2020-02-18	House	Added Co-Sponsor Rep. Jonathan "Yoni" Pizer
2020-02-18	House	Referred to Rules Committee
2020-02-18	House	First Reading
2020-02-18	House	Added Co-Sponsor Rep. Robyn Gabel
2020-02-18	House	Added Co-Sponsor Rep. La Shawn K. Ford
2020-02-14	House	Added Chief Co-Sponsor Rep. Terra Costa Howard
2020-02-14	House	Chief Co-Sponsor Changed to Rep. Grant Wehrli
2020-02-14	House	Added Chief Co-Sponsor Rep. Grant Wehrli
2020-02-14	House	Chief Co-Sponsor Changed to Rep. Marcus C. Evans, Jr.
2020-02-14	House	Added Chief Co-Sponsor Rep. Marcus C. Evans, Jr.
2020-02-14	House	Chief Co-Sponsor Changed to Rep. Fred Crespo
2020-02-14	House	Added Chief Co-Sponsor Rep. Fred Crespo
2020-02-14	House	Added Co-Sponsor Rep. Bob Morgan
2020-02-14	House	Added Co-Sponsor Rep. Mary Edly-Allen
2020-02-14	House	Added Co-Sponsor Rep. Daniel Didech
2020-02-13	House	Filed with the Clerk by Rep. Jennifer Gong-Gershowitz

Chapter	Article	Section	Citation Type	Statute Text
30	105	5.930	New Code	See Bill Text
5	140	7	Amended Code	Citation Text

Type	Source
Summary	https://www.ilga.gov/legislation/BillStatus.asp?DocNum=4888&GAID=15&DocTypeID=HB&SessionID=108&GA=101
Text	https://www.ilga.gov/legislation/101/HB/10100HB4888.htm